Strategy

Alkermes pioneers trial design in depression

Read more

What entrepreneurs should know about China

Read more

The stakes for biopharma from German drug policy

Read more

Johnson & Johnson brings partnering to the frontline

Read more

How BioCity Nottingham is rebuilding pharma

Read more

Small molecules or biologics: that's the question

Read more

Are botanical drugs a new model for pharma?

Read more

A start-up genomics company explains why open-source software is important

Read more

Time to engage with stem-cell therapy

Read more

Interview: 4-Antibody AG - How do you structure a biotech for divestment?

Read more